Luncheon Explores Menopause and Brain Health

Legacy Health Endowment hosted a Women's Health Luncheon in Turlock featuring neurologist Dr. Riley Bove.

Updated on Nov. 11, 2026 in Women’s Health

Gouache-painted editorial illustration of a single soft ochre brain form resting on a cream pedestal against a calm, airy warm-toned background.
Dr. Riley Bove, a neurologist, told attendees at a Turlock women's health luncheon hosted by Legacy Health Endowment on Nov. 4 that menopause affects the brain. AI Illustration. Upload story photo >

Live Poll

Do you feel your local health providers adequately support women through menopause?

Legacy Health Endowment hosted a Women's Health Luncheon in Turlock on Nov. 4, with Dr. Riley Bove as keynote speaker. The talk focused on menopause and how it affects the brain.

Why it matters

The keynote revisited the history of menopause care, including the Women's Health Initiative findings that led many clinicians to stop prescribing hormone therapy. Bove's telehealth sessions give residents an ongoing, no-cost way to discuss these topics.

The NIH launched the Women's Health Initiative in 1991, and its hormone therapy findings linked treatment to higher rates of heart disease, stroke and breast cancer. Individual patient implications and current prescribing trends are not addressed in the source.

The players

Dr. Riley Bove

Bove is a neurologist and clinician at the USF Weill Institute for Neurosciences who is leading the Turlock luncheon discussion and planned telehealth sessions on brain health and menopause.

Legacy Health Endowment

Legacy Health Endowment is a local health organization that hosted the Women's Health Luncheon in Turlock and coordinates the no-cost telehealth conversations.

U.S. National Institutes of Health

The NIH is the federal agency that launched the Women's Health Initiative in 1991, a study whose findings reshaped clinical use of hormone replacement therapy.

The details

Attendees were informed about the history of menopause care and the renewed examination of hormone therapy. Bove will host telehealth conversations on the brain, menopause and women's health every other month at no cost, limited to six participants per session.

Timeline

  1. 1991: NIH launches the Women's Health Initiative study, which includes testing of postmenopausal hormone therapy.

  2. Nov. 4: Women's Health Luncheon held in Turlock with Dr. Bove as keynote speaker.

  3. Jan. 12, 2027: Next Women's Health Luncheon, featuring Dr. Bridget Gannon on mental health and menopause.

Health Landscape

The Turlock luncheon revisits the NIH's Women's Health Initiative, launched in 1991, whose hormone therapy findings led many clinicians to stop prescribing hormones. The renewed examination of that research marks a shift in how menopause care is discussed locally.

Residents interested in discussing menopause and brain health can join Bove's telehealth sessions, held every other month at no cost and limited to six participants. Registration is available by calling Legacy Health Endowment at 209-250-2315.

The takeaway

Hormone therapy decisions depend on individual risk factors, so readers should discuss the Women's Health Initiative findings with a clinician before making changes. Telehealth sessions offer a no-cost place to start that conversation.

What happens next

The next Women's Health Luncheon is scheduled for Jan. 12, 2027, featuring Dr. Bridget Gannon on mental health and menopause.

Further reading

For more on related topics, explore Women's Health coverage on menopause and hormone therapy.

Source note: This article includes information reported by Turlockjournal.

Live Poll

Do you feel your local health providers adequately support women through menopause?